Loading...
Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
The diagnosis and management of drug‐induced liver injury (DILI) remains a challenge in clinical trials in drug development. The qualification of emerging biomarkers capable of predicting DILI soon after the initiation of treatment, differentiating DILI from underlying liver disease, identifying the...
Na minha lista:
| Udgivet i: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006882/ https://ncbi.nlm.nih.gov/pubmed/31314926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1571 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|